This page contains product-specific information and resources for Texas COVID-19 therapeutics providers. Providers with questions can contact therapeutics@dshs.texas.gov or call Provider Support at 833‑832‑7068, option 0.
Note: FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab when given alone
▲ Top
This page is being updated as new information becomes available.